1. |
Malmgren JA, Calip GS, Atwood MK, et al. Metastatic breast cancer survival improvement restricted by regional disparity: Surveillance, Epidemiology, and End Results and institutional analysis: 1990 to 2011. Cancer, 2020, 126(2): 390-399.
|
2. |
Yin M, Verschraegen C, Vincent VH, et al. Impact of lack of surgery on outcomes in elderly women with nonmetastatic breast cancer–A surveillance, epidemiology, and end results 18 population based study. Medicine (Baltimore), 2020, 99(3): e18745.
|
3. |
Tezcan G, Garanina EE, Zhuravleva MN, et al. Rab GTPase mediating regulation of NALP3 in colorectal cancer. Molecules, 2020, 25(20): 4834.
|
4. |
Yao A, Storr SJ, Al-Hadyan K, et al. Thioredoxin system protein expression is associated with poor clinical outcome in adult and paediatric gliomas and medulloblastomas. Mol Neurobiol, 2020, 57(7): 2889-2901.
|
5. |
Sun X, Wang M, Wang M, et al. Metabolic reprogramming in triple-negative breast cancer. Front Oncol, 2020, 10: 428.
|
6. |
Liu W, Gu J, Qi J, et al. Lentinan exerts synergistic apoptotic effects with paclitaxel in A549 cells via activating ROS-TXNIP-NLRP3 inflammasome. J Cell Mol Med, 2015, 19(8): 1949-1955.
|
7. |
王慧, 赵安帝, 杨谨. 曲妥珠单抗联合帕妥珠单抗用于HER2阳性早期乳腺癌研究进展. 华中科技大学学报 (医学版), 2020, 49(1): 111-116.
|
8. |
刘香婷, 屈佳肴, 龚珂, 等. 乳腺癌放疗抵抗分子机制研究进展. 山东医药, 2020, 60(2): 89-92.
|
9. |
Szpigel A, Hainault I, Carlier A, et al. Lipid environment induces ER stress, TXNIP expression and inflammation in immune cells of individuals with type 2 diabetes. Diabetologia, 2018, 61(2): 399-412.
|
10. |
Li Y, Miao LY, Xiao YL, et al. Hypoxia induced high expression of thioredoxin interacting protein (TXNIP) in non-small cell lung cancer and its prognostic effect. Asian Pac J Cancer Prev, 2015, 16(7): 2953-2958.
|
11. |
Jia JJ, Geng WS, Wang ZQ, et al. The role of thioredoxin system in cancer: strategy for cancer therapy. Cancer Chemother Pharmacol, 2019, 84(3): 453-470.
|
12. |
Jovanović M, Dragoj M, Zhukovsky D, et al. Novel trxr1 inhibitors show potential for glioma treatment by suppressing the invasion and sensitizing glioma cells to chemotherapy. Front Mol Biosci, 2020, 7: 586146.
|
13. |
Huang G, Pan ST. ROS-mediated therapeutic strategy in chemoradiotherapy of head and neck cancer. Oxid Med Cell Longev, 2020, 2020: 5047987.
|
14. |
Park JW, Lee SH, Woo GH, et al. Downregulation of TXNIP leads to high proliferative activity and estrogen-dependent cell growth in breast cancer. Biochem Biophys Res Commun, 2018, 498(3): 566-572.
|
15. |
Cai Z, Zhang C, Zou Y, et al. Tissue thioredoxin-interacting protein expression predicted recurrence in patients with meningiomas. Int J Clin Oncol, 2017, 22(4): 660-666.
|
16. |
Baldan F, Mio C, Lavarone E, et al. Epigenetic bivalent marking is permissive to the synergy of HDAC and PARP inhibitors on TXNIP expression in breast cancer cells. Oncol Rep, 2015, 33(5): 2199-2206.
|
17. |
Iqbal MA, Chattopadhyay S, Siddiqui FA, et al. Silibinin induces metabolic crisis in triple-negative breast cancer cells by modulating EGFR-MYC-TXNIP axis: potential therapeutic implications. FEBS J, 2021, 288(2): 471-485.
|
18. |
Zhang L, Li H, Zang Y, et al. NLRP3 inflammasome inactivation driven by miR-223-3p reduces tumor growth and increases anticancer immunity in breast cancer. Mol Med Rep, 2019, 19(3): 2180-2188.
|
19. |
Ershaid N, Sharon Y, Doron H, et al. NLRP3 inflammasome in fibroblasts links tissue damage with inflammation in breast cancer progression and metastasis. Nat Commun, 2019, 10(1): 4375.
|
20. |
曾琬琴, 殷霞, 傅小龙. 细胞焦亡在肿瘤中的研究进展. 肿瘤学杂志, 2020, 26(5): 438-443.
|
21. |
Chen YF, Qi HY, Wu FL. Euxanthone exhibits anti-proliferative and anti-invasive activities in hepatocellular carcinoma by inducing pyroptosis: preliminary results. Eur Rev Med Pharmacol Sci, 2018, 22(23): 8186-8196.
|
22. |
Kofahi HM, Taylor NG, Hirasawa K, et al. Hepatitis C virus infection of cultured human hepatoma cells causes apoptosis and pyroptosis in both infected and bystander cells. Sci Rep, 2016, 6: 37433.
|